AAO-HNS GUIDELINES Bundle (free trial)

Epistaxis (Nosebleed)

American Academy of Otolaryngology-Head and Neck Surgery Foundation GUIDELINES Apps brought to you free pf charge, courtesy of Guideline Central. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1197258

Contents of this Issue

Navigation

Page 19 of 21

20 Patient Information Table 6. Interventions for an Identified Anterior Nasal Bleeding Site Frequent Questions Emollient application Vasoconstrictor use What are my options for each category? Application of emollient creams or ointments. Application of oxymetazoline (Afrin ™ ) or other vasoconstrictors by using nose sprays or applying to cotton that is inserted in the nose. What risks are involved? is is well tolerated with no significant risks, other than the possibility of causing bleeding during application. ese medications can cause complications in some people with other health issues, such as hypertension and glaucoma. Repeated use may lead to loss of efficacy, nasal obstruction, or excessive dryness of the nasal lining (rhinitis medicamentosa). What are the benefits? ese ointments do not stop active bleeding but are useful for preventing rebleed. Low cost, non-invasive. Little cost, and these strategies provide rapid control of active bleeding. is can be done by individuals with minimal instruction. What are associated costs? Small costs of the emollient agent. Small costs of the vasoconstrictor agent. Who else can I talk to about treatment for my nosebleeds? is should be discussed with your primary care provider and an otolaryngologist, if one is seen. Your primary care provider or an ear, nose, and throat specialist (otolaryngologist) may help you understand how to apply this therapy.

Articles in this issue

Archives of this issue

view archives of AAO-HNS GUIDELINES Bundle (free trial) - Epistaxis (Nosebleed)